Skip to main content
Michael Morris, MD, Pulmonology, Fort Sam Houston, TX

MichaelJamesMorrisMD

Pulmonology Fort Sam Houston, TX

Physician

Dr. Morris is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Morris' full profile

Already have an account?

  • Office

    3551 Roger Brooke Dr
    Fort Sam Houston, TX 78234
    Phone+1 210-916-3027
    Fax+1 210-916-5187

Education & Training

  • San Antonio Uniformed Services Health Education Consortium
    San Antonio Uniformed Services Health Education ConsortiumFellowship, Pulmonary Disease and Critical Care Medicine, 1992 - 1995
  • San Antonio Uniformed Services Health Education Consortium
    San Antonio Uniformed Services Health Education ConsortiumResidency, Internal Medicine, 1987 - 1990
  • Eastern Virginia Medical School
    Eastern Virginia Medical SchoolClass of 1987

Certifications & Licensure

  • TX State Medical License
    TX State Medical License 1998 - 2026
  • MS State Medical License
    MS State Medical License 2017 - 2024
  • American Board of Internal Medicine Pulmonary Disease

Publications & Presentations

PubMed

Press Mentions

  • Lung Cancer Spit Test Fast-Tracks a San Antonio Biotech Company for Growth
    Lung Cancer Spit Test Fast-Tracks a San Antonio Biotech Company for GrowthOctober 12th, 2024
  • bioAffinity Technologies Awarded U.S. Federal Supply Schedule Contract for CyPath® Lung Test
    bioAffinity Technologies Awarded U.S. Federal Supply Schedule Contract for CyPath® Lung TestOctober 9th, 2024
  • Peer-Reviewed Study: bioAffinity Technologies’ CyPath® Lung Test Shows Potential Significant Healthcare Savings by Reducing Unnecessary Follow-up, Medical Complications and Overdiagnosis
    Peer-Reviewed Study: bioAffinity Technologies’ CyPath® Lung Test Shows Potential Significant Healthcare Savings by Reducing Unnecessary Follow-up, Medical Complications and OverdiagnosisSeptember 18th, 2024